Nimotuzumab-vinorelbine combination therapy versus other regimens in the treatment of pediatric diffuse intrinsic pontine glioma.

Ayşe Özkan Begül Yağcı Küpeli Serhan Kupeli Gulay Sezgin İbrahim Bayram

Published in: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2024)

Nimotuzumab-vinorelbine combination therapy prolonged OS by 6 months compared with temozolomide-containing chemotherapy, although the difference was not statistically significant.

Keyphrases

combination therapy
phase ii study
low grade
randomized controlled trial
squamous cell carcinoma
clinical trial
high grade
young adults
replacement therapy
childhood cancer